- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Peking Union Medical College
Total 1403 results
-
Peking Union Medical College Hospital3MUnknownBlood Coagulation Disorders | Hypothermia | Blood Loss,China
-
LI TaishengCompleted
-
Peking Union Medical College HospitalAstraZenecaRecruitingNon-small Cell Lung CancerChina
-
Junling LiUnknownApatinib in Maintenance TreatmentChina
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA IndexChina
-
Qingwei JiangRecruiting
-
Peking Union Medical College HospitalTongji UniversityRecruitingAlzheimer Disease | Mild Cognitive ImpairmentChina
-
Bing HanNot yet recruiting
-
Peking Union Medical College HospitalTsinghua UniversityRecruitingInfection ControlChina
-
Peking Union Medical College HospitalTsinghua UniversityRecruitingDroplet TransmissionChina
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Lei LiRecruitingCervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical CancerChina
-
Lei LiRecruitingRecurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility OutcomesChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
xiang yangRecruitingGestational Trophoblastic Tumor | Gestational Trophoblastic Neoplasia | Choriocarcinoma | Stage I Gestational Trophoblastic Tumor | Stage II Gestational Trophoblastic Tumor | Stage III Gestational Trophoblastic Tumor | Invasive MoleChina
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Lei LiRecruitingEndometrial Neoplasms | SurvivalChina
-
Duke Kunshan UniversityPeking Union Medical CollegeCompleted
-
Xinchen WangCompletedCritical Illness | Gastrointestinal DysfunctionChina
-
Yansong LinActive, not recruitingDTC - Differentiated Thyroid CancerChina
-
Cui XuleiCompletedAnalgesia | Hepatectomy | Paravertebral Block | Postoperative RecoveryChina
-
Cui XuleiCompletedNerve Block, Nephrectomy, AnalgesiaChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
Lei LiUnknownCervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic AccuracyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNAChina
-
Lei LiUnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasChemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 AntibodyChina
-
Yun LongCompletedHypoxia | Respiratory Failure | Mechanical Ventilation ComplicationChina
-
Lei LiUnknownEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | ChineseChina
-
Cui XuleiCompletedPain Management | Laparoscopic Renal Surgery | Nerve BlockChina
-
Lei LiUnknownEndometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial TissueChina
-
Huang YuGuangCompletedPostoperative Complications | Fluid Overload
-
Rongrong LiUnknownIodine Excess in Pregnancy | Selenium Excess in Pregnancy | Iodine Deficiency in Pregnancy | Selenium Deficiency in Pregnancy
-
Lei LiUnknownEpithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | TumorigenesisChina
-
Lei LiUnknown
-
Lei LiUnknownUterine Cervical Neoplasms | SurvivalChina
-
Fengzhi FengRecruitingRecurrent Ovarian CarcinomaChina
-
Chen MiaoRecruiting
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival PrognosisChina
-
Huang YuGuangRecruitingPostoperative ComplicationsChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immune Checkpoint Inhibitors | Overall Survival | Anti-programmed Death-1 Antibody | Metastatic Cervical Carcinoma | Persistent Advanced Cervical Carcinoma | Objective Remission Rate | Progression-free Survival | Severe Adverse EventsChina
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Survival Outcomes | Targeted Therapy | Adverse Effect | Metastatic Cervical Carcinoma | Persistent Advanced Cervical CarcinomaChina
-
Lei LiRecruitingEpithelial Ovarian Cancer | High-grade Serous Ovarian Carcinoma | Survival Outcomes | Overall Survival | Progression-free Survival | Chromosomal Instability | Somatic Copy Number Distortion | Minimal Residual LesionsChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Objective Response Rate | Overall Survival | Progression-free Survival | Epidermal Growth Factor Receptor | NimotuzumabChina
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Lei LiRecruitingQuality of Life | Cervical Cancer | Pelvic Floor Disorders | Survivorship | Overall Survival | Disease-free Survival | Urodynamics | Ovarian Reserve Function | Rectum Dynamics | Sex DysfunctionChina
-
Lei LiRecruitingLaparotomy | Laparoscopy | Locally Advanced Cervical Cancer | Neoadjuvant Chemotherapy | Adjuvant Therapy | Concurrent Chemoradiotherapy | Radical Hysterectomy | Objective Response | Systematic ChemotherapyChina
-
Lei LiRecruitingFebrile Neutropenia | Epithelial Ovarian Cancer | Adverse Event | Cost-effectiveness | Myelosuppression Adult | Colony Stimulating FactorsChina